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Abstract
Background: Acute postsurgical pain is of great interest due to potential risk of becoming chronic if not treated
properly, worsening patient’s recovery and quality of life. Twenty-eight dogs with ruptured cruciate ligaments
were divided into three groups that received intramuscular injections of 4 mg/kg of tramadol (TRA), 0.5 mg/kg
of methadone (MET0.5), or 0.7 mg/kg of methadone (MET0.7). Physiological parameters (heart and respiratory rates
and blood pressure) were evaluated at specified times: baseline (TBL), 1 (T1), 2 (T2), 4 (T4), 6 (T6), and 24 (T24) hours
after premedication. Pain scores were described by visual analogue scale (VAS), modified Glasgow Composite,
and Colorado University Acute Pain scales. Blood samples for measurement of interleukin (IL)-6 were collected
at TBL, T1, T6, and T24. This was a prospective, randomised investigation to evaluate the efficacy of tramadol and
methadone as premedications in dogs undergoing osteotomies.
Results: There were no statistically significant differences between groups with respect to age, weight, gender,
surgery time, and time to extubation. Heart rate, respiratory rate, and blood pressure values were maintained within
acceptable ranges, and a reduction was observed at T2 in MET0.5 and MET0.7 compared with TBL. Increases in VAS
scores were observed in TRA at T4 compared with TBL, T1, and T24 and between T1 and T6 (p < 0.001). In MET0.5,
there was significant increase in VAS score at T4 compared with T1 (p < 0.001). TRA and MET0.5 showed significantly
higher mean ± SD VAS scores (3.4 ± 2.5 and 2.5 ± 2.6, respectively) than MET0.7 (1.1 ± 1.5) at T4 (p < 0.001). TRA showed
greater demand of rescue analgesia (four animals in T4 and two in T6) (p < 0.037). There were no statistically significant
differences in sedation scores, Colorado Scale scores, or interleukin levels between groups and time points.
Conclusions: Methadone given as premedication in doses of 0.7 mg/kg was better at controlling pain compared with
lower doses and tramadol. However, dosage increases, administered as rescue analgesia, promoted adequate pain
control even in tramadol group. Influence of these analgesics on IL-6 release could not be demonstrated, but significant
levels were not found.
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Background
Postoperative pain management is a major concern and
influences recovery time, quality of life, and surgical out-
come [1,2]. Acute pain alters metabolic and hemodynamic
systems, facilitates the release of the inflammatory cas-
cade, and triggers a sympathetic stress response [3].
Serum values of cortisol, glucose, and interleukins may
provide important information, in association with clin-
ical parameters and pain scales, in the study of different
pain conditions and proposed treatments in dogs [4].
Pro-inflammatory cytokines, such as interleukin-6 (IL-
6), show a high association with acute pain because they
sensitise the nervous system. IL-6 levels in plasma are
detectable 60 minutes after injury, peaking at 4-6 hours,
and are proportional to tissue injury [5-9].
An adequate approach to postoperative pain control is
preventive analgesia. It has been suggested that the ad-
ministration of non-steroidal anti-inflammatory drugs
(NSAIDs), opioids, or local anaesthetics prior to injury
reduces central sensitisation, analgesic consumption, and
the use of rescue analgesia [10,11]. Opioids are com-
monly used for sedation and the treatment of post-
operative pain in small animals [4,12-14]. Although it is
well known that they may cause immune suppression in
humans by helping to control the release of inflamma-
tory substances [15-17], there is little information re-
garding opioid action on the canine immune system.
Methadone is an opioid that has recently been intro-
duced into routine veterinary medicine practice, and its
analgesic effects have been of great interest. It acts as
a Mu-opioid receptor agonist and as an N-methyl-D-
aspartate (NMDA) receptor antagonist [18,19]. Additionally,
methadone is considered to be as powerful as morphine
but causes fewer side effects, such as nausea, vomiting, and
dysphoria [20]. Tramadol is a well-known synthetic opioid
with low Mu-opioid agonist affinity (6000 times less
than morphine), and its efficacy is due to two different
mechanisms, namely, it interacts with Mu-opioid recep-
tors and has effects on serotonin and norepinephrine
reuptake. O-desmethyl tramadol (M1), a product of
tramadol hepatic metabolism, is known to present a
higher affinity for Mu receptors [21,22]. It is also
believed to have an immunostimulatory effect, as it
decreased IL-6 levels in a model of incisional pain in
rats [17].
The aim of the present study was to evaluate the ef-
fects of methadone and tramadol on postoperative pain
in dogs undergoing tibial plateau levelling osteotomy
(TPLO) and their influence on serum IL-6 levels.
Methods
Animals
Twenty-eight client-owned dogs admitted to the Orthope-
dics and Trauma Laboratory that presented with cranial
cruciate ligament ruptures were included in the study. All
the animals were judged as healthy based on physical
examinations, complete blood cell counts, and serum
biochemical analyses before surgery. Animals presenting
with any alterations in these parameters were excluded
from the study, as were those given any type of analgesic
drug prior to the study. Owners of the eligible dogs agreed
to their inclusion in the study by signing a consent agree-
ment form. Food and water were withheld for 12 hours
prior to surgery.
Experimental design
A complete physical evaluation was performed for all
animals before any other intervention. Pain scores were
assessed by several scales (the visual analogue scale,
the modified Glasgow Composite Measure Pain Scale
(CMPS), and the Colorado University Canine Acute Pain
Scale) at baseline for later comparison with the post-
operative period. Blood samples were collected for the
assessment of IL-6 levels using a specific kit for canine
serum (Quantikine®, R&D Systems, Minnesota, USA)
before premedication (baseline (TBL)) and after surgery
(1, 6, and 24 hours after premedication). Animals were
randomly assigned to three different groups as follows:
the TRA group (n = 9) received 4 mg/kg of tramadol
(Tramadon®, Cristália, São Paulo, Brazil); the MET0.5
group (n = 10) received 0.5 mg/kg of methadone (Mytedon®,
Cristália, São Paulo, Brazil); and the MET0.7 group
(n = 9) received 0.7 mg/kg of methadone. All drugs were
injected intramuscularly as premedication. The study
was approved by the Ethical Committee of Faculdade
de Medicina (0169/05) and Faculdade de Medicina
Veterinária e Zootecnia (1077/2007) from the Universidade
de São Paulo.
Procedure
Sixty minutes after premedication, the cephalic vein was
catheterised for fluid administration (lactated Ringer’s solu-
tion, Baxter Hospitalar, SP, Brazil) at a rate of 10 mL/kg/h
and for drug infusions. Anaesthesia was induced with IV
propofol (5-7 mg/kg) (Propovan®, Cristália, São Paulo,
Brazil) to achieve the desired effects (i.e., muscular relax-
ation and loss of protective reflexes), and intubation was
then performed with an adequately sized endotracheal tube.
General anaesthesia was maintained with isoflurane
(Isoflorane®, Cristália, São Paulo, Brazil) in 100% oxygen
under positive pressure ventilation (10 cmH2O) in a
circle rebreathing system, with the respiratory rate ad-
justed to maintain the end-tidal concentration of carbon
dioxide between 35 and 45 mmHg. Heart and respira-
tory rates, direct arterial blood pressure, and oxygen sat-
uration (assessed by pulse oximetry) were monitored by
a multiparameter monitor (DX 2020, Dixtal, São Paulo,
Brazil). A 20-gauge catheter was aseptically placed on
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the dorsal pedal artery and connected to the monitor’s
pressure transducer with zero reference pressure at the
level of the heart. End-tidal concentrations of isoflurane
(EtISO) and carbon dioxide (EtCO2) were monitored by
a gas analyser and capnograph (Poet® IQ, Criticare
Systems Inc., Waukesha, USA), with the EtISO initially
set at 1.4%. The gas analyser was calibrated before each
experiment with a standard gas mixture (White Martins
Gases Especiais, São Paulo, Brazil).
In the case of hypotension (MAP <65 mmHg), ephe-
drine (0.1 mg/kg) was administered. One bolus of fentanyl
(3 μcg/kg) was administered intravenously just before
starting the osteotomy. Whenever there was a change in
heart rate or blood pressure greater than 20% compared
with pre-stimulation values, a 0.1% increase in isoflurane
was administered. Temperature was maintained between
37 and 38°C with the use of a warming blanket (Gaymar
T-pump TP500, Kent Scientific Corporation, Connecticut,
USA). An 18-gauge catheter was aseptically placed in a
jugular vein to facilitate subsequent blood sample
collections. All surgeries were performed by the same
experienced surgeon (senior of the Orthopedics and
Traumatology Department).
Sedation scores were assessed 30 minutes after pre-
medication injection and at 1 and 3 hours after surgery.
A scale proposed by Valverde et al. [23], ranging from 0
to 3, was used for this purpose, with 0 = no effect, 1 =
mild effect (animal less alert but still active), 2 =moder-
ate effect (drowsy and recumbent but can walk), and 3 =
severe effect (very drowsy and unable to walk).
Physiological parameters were recorded at 1 (T1), 2
(T2), 4 (T4), 6 (T6), and 24 (T24) hours after premedica-
tion. Pain was assessed at the same time points after anal-
gesic injection, except at T2, using the VAS and modified
Glasgow Composite Measure Pain Scale [24,25], each of
which ranged from 0 to 10, where 0 indicates no pain
and 10 indicates the worst pain possible. The Colorado
University Canine Acute Pain Scale was also used and
ranged from 0 to 4, with 0 indicating minimal pain and
4 indicating severe pain (see Additional file 1). All pa-
rameters were assessed by the same observer (LBC),
who was unaware of the analgesic treatment and has
experience in pain evaluation.
If scores for the VAS, Colorado, and Glasgow scales were
higher than 4, 2, and 4, respectively, rescue analgesia was
administered as follows to reduce the influence of other
analgesic drugs on pain and IL-6 levels: 1 mg/kg of trama-
dol for the TRA group and 0.2 mg/kg of methadone for the
MET0.5 and MET0.7 groups. Animals were re-evaluated
20 minutes after the administration of rescue medication,
and if signs of pain persisted, 0.2 mg/kg of morphine was
administered and the animal was withdrawn from the
study. The animals were observed after surgery, sent home,
and then returned 24 hours later for evaluation.
The occurrence of any adverse effects, such as nausea,
vomiting, dysphoria, mydriasis, or intense salivation, was
recorded, as well as the number of animals requiring
rescue analgesia. NSAIDs were not administered during
the evaluation period, but carprofen (2.2 mg/kg twice a
day, orally) was prescribed for 10 days postoperatively,
as is usually recommended by surgeons. Blood collection
was performed at TBL, T1, T6, and T24 for measure-
ment of serum IL-6 concentrations using a commercial
ELISA kit with canine-specific monoclonal antibodies.
Blood collection, centrifugation to obtain sera, and
laboratory techniques for IL-6 measurement were per-
formed as previously described by Martins et al. [4].
Statistical analysis
Data were analysed with the Kolmogorov-Smirnov test
for normally distributed data using the software package
Sigma Plot v11.0 (Systat Software, Chicago, USA).
Physiological parameters were analysed by analysis of
variance (ANOVA) for repeated measurements, followed
by the Tukey test. Pain and sedation scores were com-
pared at different times by Friedman’s test, followed by
the Tukey test. Groups were compared by the non-
parametric Kruskal-Wallis test, followed by a post-hoc
Dunn’s test. A significance level of p < 0.05 was used,
and values are presented as the mean ± SD.
Results
The animals ranged in age from 1 to 7 years, with a
mean weight (±SD) of 33.0 (±11.2) kg. The mean surgery
time and time to extubation did not differ significantly
between groups (Table 1). A significant difference was
found in heart rate (HR), respiratory rate (RR), and dia-
stolic blood pressure (DBP) 2 hours after premedication
administration in all groups compared with baseline
values (Table 2). This result occurred because this time
point was evaluated during surgery when all animals
were under general anaesthesia with a volatile anaes-
thetic agent (isoflurane).
None of the animals required ephedrine treatment for
hypotension. No values were lower than those considered
normal under these conditions, except for the value in one
animal in the MET0.7 group that had a HR ≤ 60 beats per
minute (37 bpm) and required an intravenous atropine
sulphate injection (0.025 mg/kg). Groups that received
methadone treatment had lower mean HR values
compared with those in the tramadol treatment group,
although these differences were not significant. The mean
RR values decreased after premedication compared with
those at baseline in all groups (p < 0.001).
Sedation scores did not differ between groups or time
points, with mean values lower than 2 at every evalu-
ation (Table 3). There were no significant differences
between groups in the Colorado Pain Scale scores, and
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there were no mean values greater than 2 (Table 4). In
the TRA group, VAS scores were increased at T4 com-
pared with those at TBL, T1, and T24 (p < 0.001). In the
MET0.5 group, there was a significant increase at T4
compared with at T1 (p < 0.001). No significant differ-
ence was found within the MET0.7 group, which pre-
sented the lowest mean VAS scores at T4 (1.1 ± 1.5),
while the mean scores in the TRA and MET0.5 groups
were 3.4 ± 2.5 and 2.5 ± 2.6, respectively (p = 0.049)
(Figure 1).
Dogs in the MET0.7 group also had lower scores on
the modified GCPS (2.2 ± 1.55), indicating better pain
control compared with that provided by the other anal-
gesic treatments (3.39 ± 2.78 in the TRA group and 3.08
± 2.43 in the MET0.5 group) at T4 (p < 0.001). Six ani-
mals in the TRA group required rescue analgesia (four
at T4 and two at T6), as did one animal in the MET0.5
group at T4. Pain control was found to be adequate
thereafter, with no animal requiring further medication
(i.e., morphine).
Treatment groups did not differ significantly with re-
gard to serum IL-6 levels. An increase was observed in
all groups compared with baseline values, although this
increase was not significant.
Discussion
This study evaluated and compared the effects of metha-
done and tramadol on postoperative pain and IL-6 levels
in dogs undergoing orthopaedic surgery. VAS and modi-
fied Glasgow Composite Measure Pain Scale scores
showed that methadone yielded better pain control. An-
algesia improved with an increased dosage increment,
suggesting that methadone-induced analgesia is dose-
dependent. Nevertheless, all treatments had effects on
IL-6 by controlling its systemic release after surgery.
Adequate pain control is a major concern in the peri-
operative period. Acute pain may delay recovery and
wound healing, reduce mobilisation and food and water
consumption, and evolve to chronic postsurgical pain if
not treated properly. It is well known that opioid admin-
istration prior to surgery reduces postoperative pain
scores and analgesic drug requirements. Methadone was
recently introduced into routine hospital use as a treat-
ment for heroin addicts. However, it has been shown
Table 1 Mean surgery and extubation times by treatment
group
Group Surgery time* (mean ± SD) Extubation time*
(mean ± SD)
TRA 95.3 ± 17.4 6.6 ± 2.4
MET 0.5 98.2 ± 15.2 7.2 ± 1.6
MET 0.7 98.5 ± 12.8 7.3 ± 2.2
*measured in minutes.
Table 2 Phisyological parameters measure during time points by treatment group#
Time TBL point T1 T2 T4 T6 T24
HR TRA 136 ± 25 123 ± 12 101 ± 25b 121 ± 25b 143 ± 25*,a,b 151 ± 27a
MET 0.5 133 ± 25 107 ± 30* 83 ± 20* 110 ± 26b 106 ± 27* 121 ± 8
MET 0.7 140 ± 23 117 ± 16 64 ± 17* 86 ± 26* 105 ± 17* 140 ± 14
RR TRA 56 ± 9 46 ± 11* 10 ± 2* 26 ± 13* 36 ± 18* 55 ± 10
MET 0.5 52 ± 13 55 ± 15* 10 ± 2* 31 ± 21* 41 ± 17* 60 ± 10
MET 0.7 58 ± 7 60 ± 5* 10 ± 2* 25 ± 14* 39 ± 14* 52 ± 18
SAP TRA 183 ± 15 161 ± 17b 106 ± 17* 156 ± 25* 163 ± 24 176 ± 17a
MET 0.5 168 ± 24 146 ± 43b 90 ± 17* 147 ± 19 147 ± 23 173 ± 10
Met 0.7 179 ± 23 187 ± 21 98 ± 20* 120 ± 34 170 ± 23 165 ± 40
MAP TRA 121 ± 3 128 ± 18 89 ± 19* 104 ± 28 119 ± 25 140 ± 26
MET 0.5 126 ± 19 109 ± 31b 77 ± 13* 108 ± 23 108 ± 23 123 ± 9
MET 0.7 134 ± 24 137 ± 18 74 ± 14* 110 ± 21* 124 ± 21 122 ± 14
DAP TRA 91 ± 5 111 ± 5a 78 ± 17 87 ± 26 92 ± 23 100 ± 5a
MET 0.5 100 ± 19 85 ± 28b 60 ± 12 60 ± 18 87 ± 23 77 ± 12b
MET 0.7 106 ± 22 107 ± 18 58 ± 14 84 ± 16 96 ± 21 100 ± 18
#HR: Heart rate in beats per minute; RR: Respiratory rate in breaths per minute; SAP, MAP and DAP: Systolic, Mean and Diastolic arterial pressures in mmHg.
*:differs from TBL; a: differs from MET 0.5, b: differs from MET 0.7; p < 0.05.
Table 3 Sedation scores* by treatmetn group - median
(upper-lower value)
Group TBL T1 T4 T6 T24
TRA 0 (0-0) 1 (0-1) 1 (0-1) 0 (0-1) 0 (0-0)
MET 0.5 0 (0-0) 1 (0-2) 1 (1-2) 1 (0-1) 0 (0-0)
MET 0.7 0 (0-0) 2 (1-2) 2 (1-2) 1 (0-2) 0 (0-0)
*according to Valverde et al. [23].
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that it may also have significant effects on acute,
chronic, oncologic, and neuropathic pain, making it an
excellent alternative to the use of morphine, as metha-
done causes fewer side effects and has a multi-action
profile, acting as a Mu-opioid receptor agonist and an
NMDA receptor antagonist [20,26,27].
A control (no analgesic treatment) group was not
included in this study because it is unethical to perform
orthopaedic surgery that has the possibly of causing a
high degree of pain without analgesic administration.
The authors are aware that the absence of a control
group may decrease the confidence in the results. Tram-
adol was chosen as a positive control for methadone
because it is a well-known drug for acute pain control in
small animals, providing the same analgesic effect as
morphine in equipotent doses, and because of its immu-
nomodulatory properties [12,13,21,28].
Animals in the groups treated with methadone exhi-
bited higher sedation scores than those treated with
tramadol, in accordance with previous data [13]. In this
study, tranquilisers were not administered as part of
the premedication regimen due to the aim of achieving a
lighter degree of sedation to reduce interference with the
pain evaluation. Although sedation scores were higher in
the methadone groups, no significant differences in these
scores were observed. Methadone is claimed to promote
a more intense degree of sedation than tramadol. The
degree of sedation resulting from tramadol administration
is less intense, even when acepromazine is co-administered
[13], but this result has already been described in dogs
[29-31]. However, isolated use of opioids is recommended,
especially in animals that can be easily handled, because
the degree of sedation in this study did not exceed 1 (mild)
on the sedation scale.
Respiratory depression may be induced by the use of
opioids, depending on the dosage and administration
route [13,32]. Importantly, this effect was not observed
in this study, which may be related to the intramuscular
administration employed, which alters absorption kine-
tics and leads to fewer side effects, representing an ad-
vantage over morphine.
Dysphoria was not observed in any of the groups. This
is a very interesting finding because dysphoria is a com-
mon side effect of opioids in dogs and also an effect ob-
served in other species after tramadol administration
[33-35]. This result may be related to the dosage
employed in this study or the presence of injury/pain. In
pain-free conscious dogs, Garofalo et al. [32] reported
the presence of dysphoria in all animals after 1 mg/kg of
methadone was intravenously administered. In previous
studies where tramadol was used for the control of post-
operative pain after ovariohysterectomy, mandibulect-
omy, and maxillectomy, dysphoria was not observed
[4,12,28].
No other adverse effects were observed in any of the
treatment groups during the observation period. However,
eight animals in the TRA group exhibited intense saliva-
tion after surgery, possibly due to nausea [36]. Postopera-
tive nausea and vomiting are a major concern associated
with human anaesthesia and are described to be as limit-
ing as pain by the patients [37]. These symptoms are de-
scribed in humans after the intravenous injection of
Figure 1 Mean ± SD VAS scores measured at timepoints by treatment groups.
Table 4 Colorado University pain scale scores by
treatment group - median (upper-lower value)
Group TBL T1 T4 T6 T24
TRA 0 (0-0) 0 (0-0) 1.5 (0-3) 1 (0-2) 0 (0-1)
MET 0.5 0 (0-0) 0 (0-0) 1 (1-3) 0 (0-0) 0 (0-1)
MET 0.7 0 (0-0) 0 (0-0) 0.5 (0-2) 0 (0-1) 0 (0-0)
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tramadol and are related to prolonged administration.
None of the animals in this study presented any other side
effects during the observation period.
The absence of vomiting after tramadol and methadone
administration in the pre-anaesthetic period is considered,
in our view, an important advantage of these agents. Mor-
phine, oxymorphone, and hydromorphone are frequently
utilised as premedications in dogs and cause a high inci-
dence of vomiting [23,38], which may lead to aspiration
pneumonia [38,39]. In humans, vomiting is considered
one of the main anaesthetic complications and is asso-
ciated with a high incidence of intubation and acute
respiratory distress syndrome (ARDS) [37]. In veteri-
nary medicine, there are few published reports of this
post-anaesthetic complication, although it has recently
been shown to have a much higher incidence in animals
(0.17%) than in humans (0.014 – 0.05%) [39].
Regarding pain assessment, animals received rescue
analgesia if any of the pain scale scores were increased.
The scores for all animals returned to baseline levels
after opioid dose adjustment (as cited in the Methods
section), demonstrating that the effects of opioid anal-
gesia were dose-dependent under the study conditions.
There was a slight correlation between the three pain
scales. The modified Glasgow Composite Measure Pain
Scale showed a higher association with patients’ clinical
statuses. This result most likely occurred because this
scale allows for a more detailed assessment of behav-
iours, making it suitable as a measure of pain in clinical
situations [25].
Acute injuries, such as surgery, have been reported to
cause an early response with cytokine production. How-
ever, this response in not related to the duration of
surgery and is localised to the site of injury. IL-6 levels
show a high association with pain and are related to pain
intensity [40]. A recent study evaluating IL-6 levels in
dogs with oral cancer revealed a baseline IL-6 value of
100 pg/ml and a mean peak level of 140 pg/ml after sur-
gery during the observation period. In other studies
comparing the IL-6 levels of healthy and leishmania-
positive dogs, the authors found a higher value of
16.2 pg/ml in infected dogs [4,41]. In the present study,
there was a similar increase in IL-6 levels in all treat-
ment groups, representing an immune response to surgi-
cal stimulation, with mean values under 185 pg/ml.
These findings are in accordance with studies evaluating
IL-6 levels in dogs undergoing laparoscopic surgery, in
which values increased above baseline 2 to 6 hours after
surgery, with mean values not exceeding 100 pg/ml [42].
Conclusions
In conclusion, methadone administered as premedica-
tion at a dose of 0.7 mg/kg had a better effect on pain
control after orthopaedic surgery compared with a lower
dosage of the same drug and with tramadol. However,
the dosage increases, even tramadol increases, adminis-
tered as rescue analgesia promoted adequate pain con-
trol. The influence of the two analgesics on IL-6 release
could not be demonstrated in the present data, but
significantly high levels of IL-6 were not found.
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